These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31946583)

  • 41. Camptocormia Induced by a Dopaminergic Agonist.
    Mano T
    Clin Neuropharmacol; 2018; 41(2):70-72. PubMed ID: 29401068
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-induced camptocormia: a lesson regarding vascular Parkinsonism.
    Nakayama Y; Miwa H
    Intern Med; 2012; 51(19):2843-4. PubMed ID: 23037490
    [No Abstract]   [Full Text] [Related]  

  • 43. A case report of thoracolumbar paraspinal myopathy as the cause of camptocormia in a patient with atypical parkinsonism.
    Kim Y; Kim A; Kim A; Jeon B
    BMC Neurol; 2017 Jun; 17(1):118. PubMed ID: 28645253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Camptocormia in the differential diagnosis of hyperkyphosis and ankylosing spondylitis].
    Sarholz M; Vorgerd M; Braun J
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1736-9. PubMed ID: 22933194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Camptocormia as presenting in lower motor neuron disease with TARDBP mutation: case report.
    Filippelli E; Valentino P; Annesi G; Nisticò R; Quattrone A
    Neurol Sci; 2017 Oct; 38(10):1885-1887. PubMed ID: 28573484
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of camptocormia with botulinum toxin.
    Bertram KL; Stirpe P; Colosimo C
    Toxicon; 2015 Dec; 107(Pt A):148-53. PubMed ID: 26079953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Camptocormia or Pisa syndrome in multiple system atrophy.
    Sławek J; Derejko M; Lass P; Dubaniewicz M
    Clin Neurol Neurosurg; 2006 Oct; 108(7):699-704. PubMed ID: 16112411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of subthalamic deep brain stimulation on posture in Parkinson's disease: A blind computerized analysis.
    Roediger J; Artusi CA; Romagnolo A; Boyne P; Zibetti M; Lopiano L; Espay AJ; Fasano A; Merola A
    Parkinsonism Relat Disord; 2019 May; 62():122-127. PubMed ID: 30638820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myasthenia gravis can cause camptocormia.
    Kataoka H; Kiriyama T; Ueno S
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):469-70. PubMed ID: 21933949
    [No Abstract]   [Full Text] [Related]  

  • 50. [Parkinsonism and Camptocormia with focal spinal myopathy: case report and responsiveness to treatment].
    Diaz-Guzman J; Nunez-Enamorado N; Ruiz-Jimenez J; Garcia E; Diez-Torres I; Ricoy-Campo JR
    Rev Neurol; 2006 Oct 16-31; 43(8):466-9. PubMed ID: 17033979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delayed postirradiation camptocormia.
    Kelly L; Perju-Dumbrava LD; Thyagarajan D; Lee YC
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23960150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Camptocormia and Parkinson's disease: association or consequence?].
    Frioui S; Jemni S
    Pan Afr Med J; 2015; 20():339. PubMed ID: 26175829
    [No Abstract]   [Full Text] [Related]  

  • 53. Pisa Syndrome.
    Michel SF; Arias Carrión O; Correa TE; Alejandro PL; Micheli F
    Clin Neuropharmacol; 2015; 38(4):135-40. PubMed ID: 26166239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Camptocormia in Parkinson's disease: a review of the literature.
    Ponfick M; Gdynia HJ; Ludolph AC; Kassubek J
    Neurodegener Dis; 2011; 8(5):283-8. PubMed ID: 21389682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Camptocormia in Chinese patients with Parkinson's disease.
    Song W; Guo X; Chen K; Huang R; Zhao B; Cao B; Chen Y; Shang HF
    J Neurol Sci; 2014 Feb; 337(1-2):173-5. PubMed ID: 24360186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late onset radiation-induced camptocormia.
    Psimaras D; Maisonobe T; Delanian S; Leclercq D; Lenglet T; Feuvret L; Ricard D; Hoang-Xuan K; Pradat PF
    J Neurol; 2011 Sep; 258(9):1723-5. PubMed ID: 21431379
    [No Abstract]   [Full Text] [Related]  

  • 57. Gait dynamics in Pisa syndrome and Camptocormia: The role of stride length and hip kinematics.
    Tramonti C; Di Martino S; Unti E; Frosini D; Bonuccelli U; Rossi B; Ceravolo R; Chisari C
    Gait Posture; 2017 Sep; 57():130-135. PubMed ID: 28623760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of Mild Camptocormia with Selegiline in Patients with Parkinson's Disease.
    Yoritaka A; Mori H; Hattori N
    Eur Neurol; 2016; 76(1-2):35-9. PubMed ID: 27351804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The characteristics of camptocormia in patients with Parkinson's disease: A large cross-sectional multicenter study in Japan.
    Nakane S; Yoshioka M; Oda N; Tani T; Chida K; Suzuki M; Funakawa I; Inukai A; Hasegawa K; Kuroda K; Mizoguchi K; Shioya K; Sonoda Y; Matsuo H
    J Neurol Sci; 2015 Nov; 358(1-2):299-303. PubMed ID: 26428310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report.
    Akiyama H; Nukui S; Akamatu M; Hasegawa Y; Nishikido O; Inoue S
    BMC Neurol; 2017 Aug; 17(1):148. PubMed ID: 28774283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.